用于改造T细胞的合成生物学方法。
Synthetic biology approaches to engineer T cells.
作者信息
Wu Chia-Yung, Rupp Levi J, Roybal Kole T, Lim Wendell A
机构信息
Dept. of Cellular & Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94158, United States.
Dept. of Cellular & Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94158, United States; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA 94158, United States.
出版信息
Curr Opin Immunol. 2015 Aug;35:123-30. doi: 10.1016/j.coi.2015.06.015. Epub 2015 Jul 25.
Abstract
There is rapidly growing interest in learning how to engineer immune cells, such as T lymphocytes, because of the potential of these engineered cells to be used for therapeutic applications such as the recognition and killing of cancer cells. At the same time, our knowhow and capability to logically engineer cellular behavior is growing rapidly with the development of synthetic biology. Here we describe how synthetic biology approaches are being used to rationally alter the behavior of T cells to optimize them for therapeutic functions. We also describe future developments that will be important in order to construct safe and precise T cell therapeutics.
摘要
由于工程化免疫细胞（如T淋巴细胞）在识别和杀伤癌细胞等治疗应用方面的潜力，人们对学习如何构建这类细胞的兴趣正迅速增长。与此同时，随着合成生物学的发展，我们在逻辑上设计细胞行为的技术和能力也在迅速提高。在此，我们描述了如何利用合成生物学方法合理改变T细胞的行为，以优化其治疗功能。我们还阐述了构建安全、精准的T细胞疗法未来所需的重要进展。
相似文献
1
Synthetic biology approaches to engineer T cells.用于改造T细胞的合成生物学方法。
Curr Opin Immunol. 2015 Aug;35:123-30. doi: 10.1016/j.coi.2015.06.015. Epub 2015 Jul 25.
2
Engineering Therapeutic T Cells: From Synthetic Biology to Clinical Trials.工程化治疗性T细胞：从合成生物学到临床试验
Annu Rev Pathol. 2017 Jan 24;12:305-330. doi: 10.1146/annurev-pathol-052016-100304. Epub 2016 Dec 5.
3
Synthetic Immunology: Hacking Immune Cells to Expand Their Therapeutic Capabilities.合成免疫学：破解免疫细胞以拓展其治疗能力。
Annu Rev Immunol. 2017 Apr 26;35:229-253. doi: 10.1146/annurev-immunol-051116-052302.
4
Synthetic biology: at the crossroads of genetic engineering and human therapeutics-a Keystone Symposia report.合成生物学：基因工程与人类治疗学的十字路口——基石研讨会报告
Ann N Y Acad Sci. 2021 Dec;1506(1):98-117. doi: 10.1111/nyas.14710. Epub 2021 Nov 16.
5
A synthetic biology approach to engineering circuits in immune cells.一种在免疫细胞中工程化电路的合成生物学方法。
Immunol Rev. 2023 Nov;320(1):120-137. doi: 10.1111/imr.13244. Epub 2023 Jul 19.
6
Emerging Cellular Therapies for Cancer.新兴的癌症细胞疗法
Annu Rev Immunol. 2019 Apr 26;37:145-171. doi: 10.1146/annurev-immunol-042718-041407. Epub 2018 Dec 10.
7
Therapeutic T cell engineering.治疗性T细胞工程
Nature. 2017 May 24;545(7655):423-431. doi: 10.1038/nature22395.
8
Bottom-up synthetic immunology.自下而上的合成免疫学。
Nat Nanotechnol. 2024 Nov;19(11):1587-1596. doi: 10.1038/s41565-024-01744-9. Epub 2024 Aug 26.
9
Theranostic cells: emerging clinical applications of synthetic biology.治疗诊断一体化细胞：合成生物学的新兴临床应用。
Nat Rev Genet. 2021 Nov;22(11):730-746. doi: 10.1038/s41576-021-00383-3. Epub 2021 Jul 7.
10
Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.采用合成生物学进行癌症免疫疗法中的过继细胞转移。
Immunity. 2013 Jul 25;39(1):49-60. doi: 10.1016/j.immuni.2013.07.002.
引用本文的文献
1
Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control.增强 CAR-T 细胞疗法的安全性：时空控制的合成遗传开关。
Sci Adv. 2024 Feb 23;10(8):eadj6251. doi: 10.1126/sciadv.adj6251.
2
Synthetic Cells: From Simple Bio-Inspired Modules to Sophisticated Integrated Systems.人工合成细胞：从简单的仿生模块到复杂的集成系统。
Angew Chem Int Ed Engl. 2022 Apr 11;61(16):e202110855. doi: 10.1002/anie.202110855. Epub 2022 Mar 30.
3
T cell circuits that sense antigen density with an ultrasensitive threshold.T 细胞具有超敏阈感知抗原密度的回路。
Science. 2021 Mar 12;371(6534):1166-1171. doi: 10.1126/science.abc1855. Epub 2021 Feb 25.
4
Multiscale engineering of immune cells and lymphoid organs.免疫细胞和淋巴器官的多尺度工程
Nat Rev Mater. 2019 Jun;4(6):355-378. doi: 10.1038/s41578-019-0100-9. Epub 2019 Apr 3.
5
A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells.利用经过基因工程改造以消除同种异体反应性 T 细胞的病毒特异性 T 细胞来保护现成的细胞治疗产品的策略。
J Transl Med. 2019 Jul 24;17(1):240. doi: 10.1186/s12967-019-1988-y.
6
An immunoproteomic approach to characterize the CAR interactome and signalosome.一种免疫蛋白质组学方法，用于表征 CAR 相互作用组和信号体。
Sci Signal. 2019 Feb 12;12(568):eaap9777. doi: 10.1126/scisignal.aap9777.
7
Synthetic immunology: T-cell engineering and adoptive immunotherapy.合成免疫学：T细胞工程与过继性免疫治疗
Synth Syst Biotechnol. 2018 Sep 1;3(3):179-185. doi: 10.1016/j.synbio.2018.08.001. eCollection 2018 Sep.
8
Highly Efficient and Versatile Plasmid-Based Gene Editing in Primary T Cells.高效且多功能的基于质粒的原代 T 细胞基因编辑。
J Immunol. 2018 Apr 1;200(7):2489-2501. doi: 10.4049/jimmunol.1701121. Epub 2018 Feb 14.
9
Human c-SRC kinase (CSK) overexpression makes T cells dummy.人源 c-SRC 激酶（CSK）过表达使 T 细胞变得愚钝。
Cancer Immunol Immunother. 2018 Apr;67(4):525-536. doi: 10.1007/s00262-017-2105-9. Epub 2017 Dec 16.
10
Self-adjusting synthetic gene circuit for correcting insulin resistance.用于纠正胰岛素抵抗的自调节合成基因回路。
Nat Biomed Eng. 2017 Jan;1(1):0005. doi: 10.1038/s41551-016-0005. Epub 2016 Dec 19.
本文引用的文献
1
Adoptive cell transfer as personalized immunotherapy for human cancer.过继性细胞转移作为人类癌症的个性化免疫疗法。
Science. 2015 Apr 3;348(6230):62-8. doi: 10.1126/science.aaa4967.
2
Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma.经基因工程改造的肿瘤浸润淋巴细胞，其携带可诱导的白细胞介素-12编码基因，用于转移性黑色素瘤的免疫治疗。
Clin Cancer Res. 2015 May 15;21(10):2278-88. doi: 10.1158/1078-0432.CCR-14-2085. Epub 2015 Feb 18.
3
In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells.在体追踪人类 T 细胞揭示了基因修饰的 T 记忆干细胞长达十年的存活和活性。
Sci Transl Med. 2015 Feb 4;7(273):273ra13. doi: 10.1126/scitranslmed.3010314.
4
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery.通过控制CRISPR/Cas9递送时间实现增强的同源定向人类基因组工程。
Elife. 2014 Dec 15;3:e04766. doi: 10.7554/eLife.04766.
5
Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells.通过定制双特异性抗体与新型基因工程T细胞联合进行靶向癌症免疫治疗。
J Transl Med. 2014 Dec 13;12:347. doi: 10.1186/s12967-014-0347-2.
6
Insights into cytokine-receptor interactions from cytokine engineering.细胞因子工程对细胞因子-受体相互作用的见解。
Annu Rev Immunol. 2015;33:139-67. doi: 10.1146/annurev-immunol-032713-120211. Epub 2014 Dec 10.
7
Molecular regulation of effector and memory T cell differentiation.效应器和记忆 T 细胞分化的分子调控。
Nat Immunol. 2014 Dec;15(12):1104-15. doi: 10.1038/ni.3031.
8
Paradoxical signaling by a secreted molecule leads to homeostasis of cell levels.分泌分子的矛盾信号导致细胞水平的动态平衡。
Cell. 2014 Aug 28;158(5):1022-1032. doi: 10.1016/j.cell.2014.07.033.
9
Sending mixed messages for cell population control.传递用于细胞群体控制的混合信号。
Cell. 2014 Aug 28;158(5):973-975. doi: 10.1016/j.cell.2014.08.013.
10
Optogenetic control of chemokine receptor signal and T-cell migration.光遗传学控制趋化因子受体信号和 T 细胞迁移。
Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6371-6. doi: 10.1073/pnas.1319296111. Epub 2014 Apr 14.
Zotero 插件